Clinical significance of muscle layer interruption in T3 esophageal cancer |
| |
Authors: | Keijiro Sugimura Hiroshi Miyata Makoto Yamasaki Tsuyoshi Takahashi Yukinori Kurokawa Masaaki Motoori Kiyokazu Nakajima Shuji Takiguchi Eiichi Morii Masahiko Yano Masaki Mori Yuichiro Doki |
| |
Affiliation: | 1. Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 2-2, Yamada oka, Suita, Osaka, 565-0871, Japan 3. Department of Digestive Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Higashinari-ku, Osaka, 537-8511, Japan 2. Department of Pathology, Osaka University Graduate School of Medicine, 2-2, Yamada oka, Suita, Osaka, 565-0871, Japan
|
| |
Abstract: | Background Patients with adventitia-invading (T3) tumors, which account for the majority of esophageal cancers, are indicated for surgery but still have a poor prognosis. Subclassifying T3 tumors based on clinical outcome would be useful for selecting adequate adjuvant therapies. Methods Using 268 esophageal cancer specimens from patients without preoperative treatment, the length of the vertical and longitudinal tumor invasion, entire esophageal wall thickness, and interruption of the outer muscle layer were measured. These morphological parameters correlated with clinico-pathological factors and outcome. Results Patients were classified as T1 (38.4 %), T2 (11.9 %), T3 (38.4 %), and T4 (11.2 %) and T stage correlated well with the four morphological parameters (p < 0.0001). Each of the four morphological parameters was a significant prognostic factor. A cutoff at 20 mm of muscle layer interruption (MLI) yielded the highest prognostic significance (5-year survival 36.7 vs. 59.1 %, p = 0.009). T3 tumors with <20 mm MLI showed survival rates equivalent to T2 tumors (5-year survival 59.5 %), whereas those with ≥20 mm MLI had survival rates similar to T4 tumors (5-year survival 26.7 %). Although lymphatic and hematogenic recurrence was not significantly different, local recurrences occurred more frequently in patients with T3 tumors with ≥20 mm MLI than in those with <20 mm MLI (4.3 vs. 21.4 %, p = 0.019). Conclusions T3 esophageal cancer can be classified into subgroups according to the length of MLI. Additional local treatment would be indicated for T3 tumors with >20 mm MLI. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|